Navigation Links
Biodel Reports Positive Top-Line Results from Study of Experimental Ultra-Rapid-Acting Insulin Formulations
Date:4/15/2012

DANBURY, Conn., April 15, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today announced positive top-line results from a Phase 1 clinical trial of its product candidates, BIOD-123 and BIOD-125 -- two proprietary ultra-rapid-acting formulations of recombinant human insulin (RHI).

  • BIOD-123 and BIOD-125 achieved the Company's target pharmacokinetic, pharmacodynamic and toleration profiles in a Phase 1 clinical trial; BIOD-123 favored as lead product candidate to advance to Phase 2
  • Projecting initiation of a Phase 2 clinical trial of BIOD-123 in the third calendar quarter of 2012
  • Continuing development of ultra-rapid-acting insulin analog-based formulations with selection of candidates and initiation of a Phase 1 clinical trial projected in the second half of calendar year 2012
  • Liquid glucagon formulation for use as a rescue treatment for patients experiencing severe hypoglycemia projected for NDA submission in the fourth calendar quarter of 2013 or first calendar quarter of 2014
  • The Phase 1 clinical trial evaluated the pharmacokinetic, pharmacodynamic and injection site toleration profiles of BIOD-123 and BIOD-125 relative to Humalog®, a rapid-acting insulin analog. The objective of the trial was to identify an RHI-based formulation with pharmacokinetic and pharmacodynamic profiles similar to the Company's previous Linjeta™ formulation used in Phase 3 clinical trials, but with improved injection site toleration characteristics.  The Phase 1 clinical trial was a single-center, randomized, double-blind, three-period crossover trial in 12 patients with Type 1 diabetes.  Each study drug was administered subcutaneously on separate days with a washout period between injections. 

    Pharmacokinetic measurements were made using separate assays to quantify the active ingredients in the study drugs – RHI
    '/>"/>

    SOURCE Biodel Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report
    2. Biodel to Provide Update on Stabilized Glucagon Program at ROTH Conference Today
    3. Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation
    4. Biodel Inc. to Present at ROTH 24th Annual OC Growth Stock Conference on March 14th, 2012
    5. US Patent Office Rejection of All Claims in Final Asserted MonoSol Patent Further Supports BioDelivery Sciences Position
    6. BioDelivery Sciences and FDA Reach Agreement on BNX Development Plan
    7. Biodel Inc. to Present at 30th Annual JPMorgan Healthcare Conference on January 12th, 2012
    8. Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
    9. BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
    10. BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study
    11. Biodel to Report Fourth Quarter Fiscal Year 2011 Financial Results on December 6, 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/26/2015)... 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ... developing therapeutics that address unmet medical needs in ... Elston will present at the Marcum MicroCap ... , 4:00 PM EDTLocation: , The Grand Hyatt, ... www.juniperpharma.com, under  ,Investor, or  click here ...
    (Date:5/26/2015)... 26, 2015  PAREXEL International Corporation (NASDAQ: PRXL ... the Goldman Sachs Healthcare Conference in Palos Verdes, CA.  ... Officer, will be making a presentation on PAREXEL and ... June 9, 2015. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
    (Date:5/26/2015)... 26, 2015  OrthoAccel ® Technologies, Inc., the leader ... growth accelerating in response to continued demand from orthodontists ... available in 2,500 practice locations in the U.S. and ... AcceleDent ® is the only FDA-cleared Class II ... orthodontic treatment by as much as 50 percent.  ...
    Breaking Medicine Technology:Juniper Pharmaceuticals to Present at Investor Conference on May 28, 2015 2PAREXEL International To Present At Goldman Sachs Healthcare Conference 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3
    ... FARMINGDALE, N.Y., Nov. 2, 2011 Misonix, Inc. ... company that designs, manufactures, and markets innovative therapeutic ... cosmetic surgery, neurosurgery, laparoscopic surgery and other surgical ... Ultrasonic Bone Cutting System and the SonaStar® Ultrasonic ...
    ... 2011 Perrigo Company (Nasdaq: PRGO ; TASE) ... Drug Administration (FDA) a New Drug Application (NDA) for testosterone ... the owner of the Reference Listed Drug of its filing. ... the United States District Court for the District of New ...
    Cached Medicine Technology:Misonix Announces its Exhibition at the European Association of Neurosurgical Societies 2Misonix Announces its Exhibition at the European Association of Neurosurgical Societies 3Perrigo Confirms Filing for Testosterone Gel 1.0% and Announcement of Patent Infringement Lawsuit by Abbott 2
    (Date:5/26/2015)... On May 26, 2015, My Positive Perspective host ... Dwayne Windfall. At the start of the episode, Deierlein asks ... unique characteristics with it, so could you tell people how ... “I was reading the newspaper looking for a job when ... for a person with hustle. I responded to the ad ...
    (Date:5/26/2015)... May 26, 2015 Synthetic cannabinoids ... to an article published by International Business ... (dubbed K2, Spice, and black mamba) causes unpredictable ... these synthetic substances make it nearly impossible for ... use of the substance due to the frequency ...
    (Date:5/26/2015)... Mr. Larry Westenberg is a Licensed Clinical ... or NLP. Mr. Westenberg is recently also certified ... RRT®. While many people have learned small portions ... specific areas, Mr. Westenberg has been studying the application ... He works with people suffering the effects of ...
    (Date:5/26/2015)... 26, 2015 National Prevention Week , ... It is supported by the Substance Abuse and ... public awareness of, and action about, substance abuse as ... and coalitions are encouraged to join in promoting prevention ... related issues, and in building community partnerships. , The ...
    (Date:5/26/2015)... TX (PRWEB) May 26, 2015 Texas ... opening of its newest clinic on May 25, 2015 in ... 1919 Rogers Road, Suite 102 in Westover Hills and offers ... 7 P.M. , “We’re thrilled about opening this new ... more of our neighbors in San Antonio and to show ...
    Breaking Medicine News(10 mins):Health News:My Positive Perspective Broadcasts Episode with Oceans 6 to Discuss Their Role in Helping the Community 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3Health News:TexPTS Announces New Clinic in San Antonio 2
    ... Nielsen Company , a leading global information and media company ... advertising and design competitions, announced today that the first-ever ... at www.CLIOHealthcare.com . The submission deadline is August ... June 30, 2009. , , "We are looking forward to ...
    ... psychiatrists and psychologists from The Child Study Center at NYU ... parents face today , , Expert advice and tips ... disorders, depression, anxiety, homosexuality and more explored on marathon of Doctor ... 1 SIRIUS XM Radio (Nasdaq: SIRI ) today ...
    ... pilot prevention program targeting fifth graders and their younger ... on Drug Abuse as part of the National Institutes ... award is for two years. The program aims ... and thereby decrease risky behavior and use of drugs ...
    ... determined that movie characters who smoke, regardless of whether they ... smoking. The study, published in the July 2009 issue of ... Matters More, Good Guys or Bad Guys?" "Previous studies ... initiation of smoking by adolescents, and we wanted to dig ...
    ... for Dedication to Improving Animal Health and Well-Being , ... for the third annual Thank Your Vet for a ... The national short-essay contest honors America,s veterinarians for their ... have with our pets. The nationwide essay contest runs ...
    ... National Alliance on Mental Illness (NAMI) reminds Americans that July ... a time for public education about serious mental illness in ... House of Representatives designated July as Bebe Moore Campbell National ... African American novelist and journalist, who also was a voice ...
    Cached Medicine News:Health News:Nielsen Announces First-Ever CLIO Healthcare Awards Now Accepting Entries 2Health News:Nielsen Announces First-Ever CLIO Healthcare Awards Now Accepting Entries 3Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 2Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 3Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 4Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 5Health News:SIRIUS XM's Doctor Radio to Air July 4th Family Special '24 Hours About Our Kids: Why Kids Behave the Way They Do' 6Health News:Both good/bad movie characters who smoke influence teens to do the same 2Health News:Search for America's Best Veterinarian Continues With Third Annual 'Thank Your Vet for a Healthy Pet(R)' Contest 2Health News:NAMI Observes Minority Mental Health Awareness Month 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    Medicine Products: